Hasselt, Belgium, December 19, 2017. | Steven Verhoeven, previously Agilent’s head of genomics software, will join UgenTec to take up the role of chief executive officer, the current role of founder Wouter Uten. Verhoeven will be responsible for continuing the exponential growth of UgenTec, exploring new markets & maintaining investor relations.
UgenTec is growing very rapidly, recently disclosing deals with commercial diagnostic companies such as R-Biopharm, SpeeDx, and Fast Track Diagnostics. Besides human clinical diagnostics, the company is expanding to other markets such as agri-genomics, human genetics, food diagnostics, animal health and companion diagnostics.
At Agilent Technologies, Verhoeven was responsible for strategy and success of a suite of software products in clinical and translational genomics. His experience lies in leading fast growing teams and scaling up organizations from a customer-centric perspective. Verhoeven previously also led operations at the Belgian genomics software company Cartagenia as COO and built out an international delivery organization as VP of Professional Services for BAE Systems Detica.
“I’m excited and honored to join the team at UgenTec.” says Steven Verhoeven, “With a strong team and a unique solution, they are uniquely positioned to meet the increasing demand for automated data analysis and workflow support in clinical diagnostics and other markets.”
Current CEO Wouter Uten will move towards a role a Chief Operational Officer, while Tom Martens will continue his work as Chief Commercial Officer.
“Tom and I started the company in 2014 with a plan to become the leading global PCR software company for routine molecular diagnostics” said Wouter Uten, “Steven’s experience in scaling life science software companies will help us fulfill that plan. We are very excited to be able to strengthen our management team with someone with his experience in international growth”
Verhoeven will take up his role of CEO on January 15, 2018 and will move from Boston, MA to Belgium.
